News for Janux Therapeutics, Inc. (JANX)

Published at

Mar 6, 2025 12:53 AM

by insidermonkey.com

positive

positive

Janux Therapeutics, Inc. (JANX): Among The Stocks With At Least $30 Million In Insider Spending Recently

We recently compiled a list of the 10 Stocks With At Least $30 Million In Insider Spending Recently. In this article, we are going to take a look at where Janux Therapeutics, Inc.

JANX

Read more →
Published at

Feb 28, 2025 8:22 AM

by gurufocus.com

positive

positive

Decoding Janux Therapeutics Inc (JANX): A Strategic SWOT Insight

Janux Therapeutics Inc (JANX) exhibits a robust proprietary technology platform with potential in cancer treatment.The company faces significant losses and has

JANX

Read more →
Published at

Feb 27, 2025 11:07 PM

by gurufocus.com

positive

positive

Janux Therapeutics Inc (JANX) Reports Strong 2024 Financial Results and Clinical Progress

Janux Therapeutics Inc (JANX), a clinical-stage biopharmaceutical company specializing in novel immunotherapies, announced its financial results for the fourth

JANX

Read more →
Published at

Feb 27, 2025 11:00 PM

by gurufocus.com

negative

negative

Janux Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

[url="]Janux Therapeutics, Inc.[/url] (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies b

JANX

Read more →
Published at

Feb 24, 2025 7:07 PM

by insidermonkey.com

neutral

neutral

Janux Therapeutics, Inc. (JANX): Among the Oversold Biotech Stocks to Buy Now

We recently published a list of 10 Oversold Biotech Stocks to Buy Now. In this article, we are going to take a look at where Janux Therapeutics, Inc.

JANX

Read more →
Published at

Feb 23, 2025 12:51 PM

by gurufocus.com

positive

positive

RA CAPITAL MANAGEMENT, L.P. Increases Stake in Solid Biosciences Inc

On February 19, 2025, RA CAPITAL MANAGEMENT, L.P. (Trades, Portfolio) made a significant move by acquiring an additional 3,659,374 shares of Solid Biosciences I

SLDB RYTM.MX RYTM PCVX JANX

Read more →
Published at

Feb 15, 2025 5:24 PM

by gurufocus.com

positive

positive

RA Capital Management, L.P. Expands Stake in Verona Pharma PLC

On December 31, 2024, RA Capital Management, L.P. made a significant move by acquiring an additional 2,768,289 shares of Verona Pharma PLC. This transaction inc

VRNA RYTM.MX RYTM PCVX JANX

Read more →
Published at

Feb 15, 2025 5:21 PM

by gurufocus.com

positive

positive

RA CAPITAL MANAGEMENT, L.P. Reduces Stake in Recursion Pharmaceuticals Inc

On December 31, 2024, RA CAPITAL MANAGEMENT, L.P. (Trades, Portfolio) executed a significant transaction involving Recursion Pharmaceuticals Inc (RXRX). The fir

RYTM.MX RYTM RXRX PCVX JANX

Read more →
Published at

Feb 15, 2025 5:19 PM

by gurufocus.com

positive

positive

RA CAPITAL MANAGEMENT, L.P. Acquires Additional Shares in Dianthus Therapeutics Inc

On December 31, 2024, RA CAPITAL MANAGEMENT, L.P. (Trades, Portfolio), a prominent investment firm, expanded its stake in Dianthus Therapeutics Inc (DNTH) by ac

RYTM.MX RYTM PCVX JANX

Read more →
Published at

Feb 15, 2025 5:17 PM

by gurufocus.com

positive

positive

RA CAPITAL MANAGEMENT, L.P. Reduces Stake in 4D Molecular Therapeutics Inc

On December 31, 2024, RA CAPITAL MANAGEMENT, L.P. (Trades, Portfolio) executed a significant transaction involving 4D Molecular Therapeutics Inc (FDMT). The fir

RYTM.MX RYTM PCVX JANX FDMT

Read more →
Published at

Feb 15, 2025 11:42 AM

by gurufocus.com

positive

positive

Paradigm Biocapital Advisors LP Expands Stake in Janux Therapeutics Inc

On December 31, 2024, Paradigm Biocapital Advisors LP (Trades, Portfolio) executed a significant transaction by acquiring an additional 907,412 shares of Janux

RVMD JANX ARGX.BR ARGX ARGNF A1RG34.SA

Read more →
Published at

Feb 14, 2025 10:11 PM

by gurufocus.com

positive

positive

Janus Henderson Group PLC Increases Stake in Janux Therapeutics Inc

Significant Stock Transaction by Janus Henderson Group PLC On December 31, 2024, Janus Henderson Group PLC executed a notable stock transaction involving Janux

NVDAD.BA NVDAC.BA NVDA.MI MSFTD.BA MSFTCL.SN MSFTC.BA MSFTB.BA MSFT.MI JHG.AX JHG JANX APC.DE AMZNCL.SN AMZN.SN AMZN.MX AMZN AMZ.DE AAPLD.BA AAPLCL.SN AAPLC.BA AAPL.SN AAPL.NE AAPL.MX AAPL.BA AAPL 0RPW.L

Read more →
Published at

Jan 9, 2025 3:02 AM

by gurufocus.com

positive

positive

Insider Sell: David Campbell Sells 5,000 Shares of Janux Therapeutics Inc (JANX)

On January 7, 2025, David Campbell, President and Chief Executive Officer of Janux Therapeutics Inc, sold 5,000 shares of the company, according to a SEC Filing

JANX

Read more →
Published at

Jan 8, 2025 3:00 PM

by seekingalpha.com

positive

positive

Janux Therapeutics: mCRPC TAM And Promising JANX007’s Phase 1 Data (NASDAQ:JANX)

Janux Therapeutics, a biotech with cutting-edge platforms, shows promising results in cancer treatment, making it a top buyout candidate for 2025. Read my JANX thesis.

JANX

Read more →
Published at

Dec 28, 2024 3:01 AM

by gurufocus.com

positive

positive

Insider Sell: David Campbell Sells 25,000 Shares of Janux Therapeutics Inc (JANX)

On December 24, 2024, David Campbell, President and Chief Executive Officer of Janux Therapeutics Inc, sold 25,000 shares of the company. Following this transac

JANX

Read more →
Published at

Dec 28, 2024 2:01 AM

by investing.com

positive

positive

Janux therapeutics CEO David Campbell sells $1.4 million in stock By Investing.com

Janux therapeutics CEO David Campbell sells $1.4 million in stock

JANX

Read more →
Published at

Dec 20, 2024 11:04 AM

by investing.com

negative

negative

The Top 5 Mid Cap Stocks of 2024

Stocks Analysis by ValueWalk (Dave Kovaleski) covering: S&P 500, Bitcoin US Dollar, GeneDx Holdings Corp, Janux Therapeutics Inc. Read ValueWalk (Dave Kovaleski)'s latest article on Investing.com

JANX

Read more →
Published at

Dec 7, 2024 1:11 AM

by gurufocus.com

mixed

mixed

RA Capital Management, L.P. Acquires Significant Stake in Alector Inc

On November 29, 2024, RA Capital Management, L.P. made a strategic move by acquiring 9,695,228 shares of Alector Inc (ALEC) at a transaction price of $2.59 per

ALEC RYTM.MX RYTM PCVX JANX

Read more →
Published at

Dec 3, 2024 9:31 PM

by gurufocus.com

mixed

mixed

Agenus (AGEN) Stock Drops 5.50% Amid Biotech Sector Decline

Agenus Inc. (AGEN), a biotechnology company, saw its stock price plummet by 5.50%, trading at $3.53 per share with a trading volume of 480,929 shares. The compa

JANX PPBT AGEN

Read more →
Published at

Dec 3, 2024 2:55 PM

by rttnews.com

mixed

mixed

Pre-market Movers: CTNT, NLSP, PSQH, JANX, CHRS…

North Carolina-based Cheetah Net Supply Chain Service Inc. (CTNT) is up over 267 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

NLSPW NLSP JANX CLSK CHRS VMAR VIR

Read more →